Home » Stocks » HCYT

H-CYTE, Inc. (HCYT)

Stock Price: $0.0400 USD -0.0060 (-13.04%)
Updated Jan 19, 2021 3:46 PM EST - Market closed
Market Cap 6.66M
Revenue (ttm) 3.53M
Net Income (ttm) -26.33M
Shares Out 116.97M
EPS (ttm) -0.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $0.0400
Previous Close $0.0460
Change ($) -0.0060
Change (%) -13.04%
Day's Open 0.0400
Day's Range 0.0311 - 0.0460
Day's Volume 94,977
52-Week Range 0.006 - 0.196

News

There are no news available yet.

About HCYT

H-CYTE, a medical biosciences company, develops and implements various treatment options in regenerative medicine to treat chronic lung diseases. It engages in the development of L-CYTE-01 for the treatment of chronic obstructive pulmonary diseases. The company is headquartered in Tampa, Florida.

Industry
Medical Devices
Stock Exchange
OTCMKTS
Ticker Symbol
HCYT
Full Company Profile

Financial Performance

In 2019, H-CYTE, Inc.'s revenue was $8.35 million, an increase of 5.88% compared to the previous year's $7.88 million. Losses were -$29.81 million, 578.4% more than in 2018.

Financial Statements